BRKR PE Ratio & Valuation,Is BRKR Overvalued

BRKR Relative Valuation

BRKR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BRKR is overvalued; if below, it's undervalued.

Historical Valuation

Bruker Corp (BRKR) is now in the Fair zone, suggesting that its current forward PE ratio of 22.59 is considered Fairly compared with the five-year average of 26.68. The fair price of Bruker Corp (BRKR) is between 42.82 to 64.19 according to relative valuation methord.

Relative Value

Fair Zone

42.82-64.19

Current Price：45.73

Fair

22.85

14.22

EV/EBITDA

Bruker Corp. (BRKR) has a current EV/EBITDA of 14.22. The 5-year average EV/EBITDA is 17.64. The thresholds are as follows: Strongly Undervalued below 10.93, Undervalued between 10.93 and 14.28, Fairly Valued between 20.99 and 14.28, Overvalued between 20.99 and 24.35, and Strongly Overvalued above 24.35. The current Forward EV/EBITDA of 14.22 falls within the Undervalued range.

17.07

EV/EBIT

Bruker Corp. (BRKR) has a current EV/EBIT of 17.07. The 5-year average EV/EBIT is 19.83. The thresholds are as follows: Strongly Undervalued below 12.89, Undervalued between 12.89 and 16.36, Fairly Valued between 23.30 and 16.36, Overvalued between 23.30 and 26.77, and Strongly Overvalued above 26.77. The current Forward EV/EBIT of 17.07 falls within the Historic Trend Line -Fairly Valued range.

1.99

Bruker Corp. (BRKR) has a current PS of 1.99. The 5-year average PS is 3.31. The thresholds are as follows: Strongly Undervalued below 1.33, Undervalued between 1.33 and 2.32, Fairly Valued between 4.31 and 2.32, Overvalued between 4.31 and 5.30, and Strongly Overvalued above 5.30. The current Forward PS of 1.99 falls within the Undervalued range.

20.86

P/OCF

Bruker Corp. (BRKR) has a current P/OCF of 20.86. The 5-year average P/OCF is 24.86. The thresholds are as follows: Strongly Undervalued below 11.19, Undervalued between 11.19 and 18.03, Fairly Valued between 31.70 and 18.03, Overvalued between 31.70 and 38.53, and Strongly Overvalued above 38.53. The current Forward P/OCF of 20.86 falls within the Historic Trend Line -Fairly Valued range.

26.51

P/FCF

Bruker Corp. (BRKR) has a current P/FCF of 26.51. The 5-year average P/FCF is 34.76. The thresholds are as follows: Strongly Undervalued below 8.75, Undervalued between 8.75 and 21.75, Fairly Valued between 47.76 and 21.75, Overvalued between 47.76 and 60.76, and Strongly Overvalued above 60.76. The current Forward P/FCF of 26.51 falls within the Historic Trend Line -Fairly Valued range.

Bruker Corp (BRKR) has a current Price-to-Book (P/B) ratio of 2.81. Compared to its 3-year average P/B ratio of 6.33 , the current P/B ratio is approximately -55.61% higher. Relative to its 5-year average P/B ratio of 7.90, the current P/B ratio is about -64.46% higher. Bruker Corp (BRKR) has a Forward Free Cash Flow (FCF) yield of approximately -0.15%. Compared to its 3-year average FCF yield of 1.68%, the current FCF yield is approximately -109.21% lower. Relative to its 5-year average FCF yield of 1.83% , the current FCF yield is about -108.44% lower.

2.84

P/B

Median3y

6.33

Median5y

7.90

-0.15

FCF Yield

Median3y

1.68

Median5y

1.83

Competitors Valuation Multiple

The average P/S ratio for BRKR's competitors is , providing a benchmark for relative valuation. Bruker Corp Corp (BRKR) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -0.45%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of BRKR decreased by 22.09% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -89.29 to -289.53.

The secondary factor is the Revenue Growth, contributed -0.45%to the performance.

Overall, the performance of BRKR in the past 1 year is driven by P/E Change. Which is more unsustainable.

-0.45%

864.40M → 860.50M

Revenue Growth

-245.92%

4.66 → -6.80

Margin Expansion

224.28%

-89.29 → -289.53

P/E Change

-22.09%

58.62 → 45.67

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Bruker Corp (BRKR) currently overvalued or undervalued?

What is Bruker Corp (BRKR) fair value?

BRKR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Bruker Corp (BRKR) is between 42.82 to 64.19 according to relative valuation methord.

How does BRKR's valuation metrics compare to the industry average?

What is the current P/B ratio for Bruker Corp (BRKR) as of Dec 16 2025?

As of Dec 16 2025, Bruker Corp (BRKR) has a P/B ratio of 2.81. This indicates that the market values BRKR at 2.81 times its book value.

What is the current FCF Yield for Bruker Corp (BRKR) as of Dec 16 2025?

As of Dec 16 2025, Bruker Corp (BRKR) has a FCF Yield of -0.15%. This means that for every dollar of Bruker Corp’s market capitalization, the company generates -0.15 cents in free cash flow.

What is the current Forward P/E ratio for Bruker Corp (BRKR) as of Dec 16 2025?

As of Dec 16 2025, Bruker Corp (BRKR) has a Forward P/E ratio of 22.59. This means the market is willing to pay $22.59 for every dollar of Bruker Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Bruker Corp (BRKR) as of Dec 16 2025?

As of Dec 16 2025, Bruker Corp (BRKR) has a Forward P/S ratio of 1.99. This means the market is valuing BRKR at $1.99 for every dollar of expected revenue over the next 12 months.

BRKR Valuation